Quantification of [18F]-FDG uptake in atherosclerotic plaque: Impact of renal function

Annals of Nuclear Medicine

Volumn 25, Issue 8, 2011, Pages 586-591

  Derlin, Thorsten ^a   Habermann, Christian R ^a   Hahne, Jasmin D ^a   Apostolova, Ivayla ^b   Klutmann, Susanne ^a   Mester, Janos ^a   Buchert, Ralph ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

18F FDG; Atherosclerosis; PET; Plaque; Renal function; SUV

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL WALL; CARDIOVASCULAR RISK; CLINICAL TRIAL; DRUG UPTAKE; EVALUATION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; ATHEROSCLEROSIS; COMPUTER ASSISTED TOMOGRAPHY; KIDNEY; KIDNEY FUNCTION TEST; METHODOLOGY; MIDDLE AGED; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; RISK FACTOR; SCINTISCANNING;

ADULT; AGED; ATHEROSCLEROSIS; FEMALE; FLUORODEOXYGLUCOSE F18; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; POSITRON-EMISSION TOMOGRAPHY; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 81855193980     PISSN: 09147187     EISSN: 18646433     Source Type: Journal    
DOI: 10.1007/s12149-011-0503-1     Document Type: Article

References (20)

1. JA Thie 2004 Understanding the standardized uptake value, its methods, and implications for usage J Nucl Med 45 1431 1434 15347707 (Pubitemid 47618494)
2. R Boellaard NC Krak OS Hoekstra AA Lammertsma 2004 Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study J Nucl Med 45 1519 1527 15347719 (Pubitemid 47618506)
3. E Laffon AL Cazeau A Monet H de Clermont P Fernandez R Marthan, et al. 2008 The effect of renal failure on 18F-FDG uptake: a theoretic assessment J Nucl Med Technol 36 200 202 19008285 10.2967/jnmt.107.049627
4. J Wassélius S Larsson H Jacobsson 2009 Time-to-time correlation of high-risk atherosclerotic lesions identified with [(18)F]-FDG-PET/CT Ann Nucl Med 23 59 64 19205839 10.1007/s12149-008-0207-3
5. A Rominger T Saam S Wolpers CC Cyran M Schmidt S Foerster, et al. 2009 18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease J Nucl Med 50 1611 1620 19759117 10.2967/jnumed.109.065151
6. JH Rudd KS Myers S Bansilal J Machac CA Pinto C Tong, et al. 2008 Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations J Nucl Med 49 871 878 18483100 10.2967/jnumed.107.050294 (Pubitemid 351793426)
7. T Saam A Rominger S Wolpers K Nikolaou C Rist M Greif, et al. 2010 Association of inflammation of the left anterior descending coronary artery with cardiovascular risk factors, plaque burden and pericardial fat volume: a PET/CT study Eur J Nucl Med Mol Imaging 37 1203 1212 20300933 10.1007/s00259-010-1432- 2
8. BM Gallagher JS Fowler NI Gutterson RR MacGregor CN Wan AP Wolf 1978 Metabolic trapping as a principle of radiopharmaceutical design: some factors responsible for the biodistribution of [18F] 2-deoxy-2-fluoro-d-glucose J Nucl Med 19 1154 1161 214528 1:CAS:528:DyaE1MXisVKi (Pubitemid 9059983)
9. N Tahara H Kai M Ishibashi H Nakaura H Kaida K Baba, et al. 2006 Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography J Am Coll Cardiol 48 1825 1831 17084257 10.1016/j.jacc.2006.03.069 1:CAS:528:DC%2BD28XhtFOjtb%2FE (Pubitemid 44648621)
10. M Ogawa Y Magata T Kato K Hatano S Ishino T Mukai, et al. 2006 Application of 18F-FDG PET for monitoring the therapeutic effect of antiinflammatory drugs on stabilization of vulnerable atherosclerotic plaques J Nucl Med 47 1845 1850 17079818 1:CAS:528:DC%2BD28Xht1Gru73L (Pubitemid 47545007)
11. AS Levey JP Bosch JB Lewis T Greene N Rogers D Roth 1999 A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in Renal Disease Study Group Ann Intern Med 130 461 470 10075613 1:CAS:528:DyaK1MXitFChs7k%3D (Pubitemid 29135798)
12. GG Bural DA Torigian W Chamroonrat M Houseni W Chen S Basu 2008 FDG-PET is an effective imaging modality to detect and quantify age-related atherosclerosis in large arteries Eur J Nucl Med Mol Imaging 35 562 569 17957367 10.1007/s00259-007-0528-9 (Pubitemid 351674338)
13. H Zhuang M Pourdehnad ES Lambright AJ Yamamoto M Lanuti P Li PD Mozley, et al. 2001 Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes J Nucl Med 42 1412 1417 11535734 1:STN:280:DC%2BD3Mvptlersg%3D%3D (Pubitemid 32852620)
14. R Agarwal 2007 Effects of statins on renal function Mayo Clin Proc 82 1381 1390 17976359 10.4065/82.11.1381 1:CAS:528:DC%2BD2sXhtlOhtLvL (Pubitemid 350060135)
15. DH Walter S Dimmeler AM Zeiher 2004 Effects of statins on endothelium and endothelial progenitor cell recruitment Semin Vasc Med 4 385 393 15861319 10.1055/s-2004-869595 (Pubitemid 40577827)
16. S Bianchi R Bigazzi A Caiazza VM Campese 2003 A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease Am J Kidney Dis 41 565 570 12612979 10.1053/ajkd.2003.50140 1:CAS:528:DC%2BD3sXisVOjurk%3D (Pubitemid 36278373)
17. VG Athyros DP Mikhailidis AA Papageorgiou AN Symeonidis AN Pehlivanidis VI Bouloukos, et al. 2004 The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study J Clin Pathol 57 728 734 15220366 10.1136/jcp.2003.012989 1:CAS:528: DC%2BD2cXmslWktrs%3D (Pubitemid 38901488)
18. AS Levey 1990 Measurement of renal function in chronic renal disease Kidney Int 38 167 184 2200925 10.1038/ki.1990.182 1:STN:280:DyaK3czkvVWhsw%3D%3D (Pubitemid 20209447)
19. BL Kasiske MA Andany B Danielson 2002 A thirty percent chronic decline in inverse serum creatinine is an excellent predictor of late renal allograft failure Am J Kidney Dis 39 762 768 11920342 10.1053/ajkd.2002.31996 (Pubitemid 34263350)
20. E Brandstrom A Grzegorczyk L Jacobsson P Friberg A Lindahl M Aurell 1998 GFR measurement with iohexol and 51Cr-EDTA A comparison of the two favoured GFR markers in Europe Nephrol Dial Transplant 13 1176 1182 9623550 10.1093/ndt/13.5.1176 1:STN:280:DyaK1c3osFSjug%3D%3D (Pubitemid 28227194)